Lorraine Laham, PhD, MBA
Director, Licensing & Strategic Alliances
Lorraine joined OTL in October of 2016 to support the department’s business development and licensing efforts for partnering the university’s early product opportunities with industry. She has over 15 years of experience working with biotech, pharma, device and academic companies in roles focusing on the identification, evaluation, transactions negotiations, IP management and R&D development for advancing the commercialization of innovative early-stage life sciences platforms, technologies and product opportunities.
Lorraine has a PhD in Cell & Developmental Biology from Harvard Medical School with her dissertation specializing in control of rearrangements in the actomyosin cytoskeleton and also an MBA from Boston University. Before her move into technology, she completed her post-doctoral training at Dana-Farber Cancer Institute specializing in growth-factor mediated signal transduction pathways for development and cancer.